Search Results - "Lamy, F. X."

Epidemiology of Posttransplant Lymphoproliferative Disorders in Adult Kidney and Kidney Pancreas Recipients: Report of the French Registry and Analysis of Subgroups of Lymphomas by Caillard, S., Lamy, F. X., Quelen, C., Dantal, J., Lebranchu, Y., Lang, P., Velten, M., Moulin, B

“…A registry of posttransplant lymphoproliferative disorders (PTLD) was set up for the entire population of adult kidney transplant recipients in France. Cases…”
Get full text

Pharmacotherapeutic strategies for patients treated for depression in UK primary care: a database analysis by Lamy, FX, Chollet, J., Clay, E., Brignone, M., Rive, B., Saragoussi, D.

“…Abstract Objective: To investigate long-term patterns of antidepressant treatment in patients in primary care in the UK, and to assess their healthcare…”
Get full text

The use of adjunctive antipsychotics to treat depression in UK primary care by Lamy, F. X., Saragoussi, D., Johnson, M. E., Guiraud-Diawara, A., Jørgensen, K. T., Loze, J. Y., Maguire, A.

“…Objective: Adjunctive antipsychotic therapy can be prescribed to patients with depression who have inadequate response to antidepressants. This study aimed to…”
Get full text

415P Comparison of cetuximab every 2 weeks versus standard once-weekly administration for the first-line treatment of RAS wild-type metastatic colorectal cancer among patients with left- and right-sided primary tumor location by Kasper, S., Cheng, A-L., Rouyer, M., Foch, C., Lamy, F-X., Esser, R., Batech, M., Wong, C.M.J., Zhang, A., Brodowicz, T., Zielinski, C.

Get full text

584P - Noninferiority on overall survival of every-2-weeks vs weekly schedule of cetuximab for first-line treatment of RAS wild-type metastatic colorectal cancer by Kasper, S., Cheng, A.-L., Overkamp, F., Rouyer, M., Foch, C., Lamy, F.-X., Esser, R., Messinger, D., Rothe, V., Chen, W., Brodowicz, T., Zielinski, C.C.

“…Cetuximab (CET) in combination with chemotherapy is approved for a once-weekly (q1w) schedule at an initial dose of 400mg/m², followed by weekly doses of…”
Get full text

Noninferiority on overall survival of every-2-weeks vs weekly schedule of cetuximab for first-line treatment of RAS wild-type metastatic colorectal cancer by Kasper, S., Cheng, A.-L., Overkamp, F., Rouyer, M., Foch, C., Lamy, F.-X., Esser, R., Messinger, D., Rothe, V., Chen, W., Brodowicz, T., Zielinski, C.C.

Get full text

584PNoninferiority on overall survival of every-2-weeks vs weekly schedule of cetuximab for first-line treatment of RAS wild-type metastatic colorectal cancer by Kasper, S, Cheng, A-L, Overkamp, F, Rouyer, M, Foch, C, Lamy, F-X, Esser, R, Messinger, D, Rothe, V, Chen, W, Brodowicz, T, Zielinski, C C

“…Abstract Background Cetuximab (CET) in combination with chemotherapy is approved for a once-weekly (q1w) schedule at an initial dose of 400 mg/m², followed by…”
Get full text

Economic Burden of Major Depressive Disorder (Mdd) in Five European Countries: Description of Resource use by Health State by Painchault, C, Brignone, M, Lamy, F.X, Diamand, F, Saragoussi, D

Get full text

History of Antidepressant use Among Primary Care Depressed Patients Switching Treatments in the United Kingdom by Lamy, F.X, Quelen, C, Brignone, M, Ferchichi, S, Vataire, A.L, Rive, B, Saragoussi, D

Get full text

Augmenter le prélèvement d’organes sur donneurs décédés en mort encéphalique, Cristal action : un nouvel outil pour les établissements de santé en France by Jacob, J. -P., Lamotte, C., Lamy, F. -X., Pessione, F., Dubé, L., Dubois, C.

“…Résumé En France, l’amélioration de l’accès à la greffe passe en premier par une augmentation du prélèvement des donneurs d’organes hospitalisés dans les…”
Get full text

Psychometric validation of the Perceived Deficits Questionnaire-Depression (PDQ-D) instrument in US and UK respondents with major depressive disorder by Lam, Raymond W, Lamy, François-Xavier, Danchenko, Natalya, Yarlas, Aaron, White, Michelle K, Rive, Benoît, Saragoussi, Delphine

“…Although depression and cognitive dysfunction are connected, limited tools exist to capture the patient's perspective on cognitive dysfunction and its impact…”
Get full text

The role of the French Agence de la biomédecine in lung transplantation by Dorent, R, Lamy, F-X, Cantrelle, C

“…The Agence de la biomédecine is a public institution in charge of organs tissues cells transplantation, reproduction, embryology and genetics. It interacts…”
Get full text

Le rôle de l'Agence de la biomédecine dans la greffe pulmonaire: Transplantation pulmonaire by DORENT, R, LAMY, F.-X, CANTRELLE, C

Get full text

Le rôle de l’Agence de la biomédecine dans la greffe pulmonaire by Dorent, R., Lamy, F.-X., Cantrelle, C.

“…L’Agence de la biomédecine est un établissement public compétent dans les domaines de la greffe d’organes de tissus et de cellules, de la procréation, de…”
Get full text

Augmenter le prélèvement d'organes sur donneurs décédés en mort encéphalique, Cristal action: un nouvel outil pour les établissements de santé en France : URGENCES by JACOB, J.-P, LAMOTTE, C, LAMY, F.-X, PESSIONE, F, DUBE, L, DUBOIS, C

Get full text